Factors Affecting Readmission Rates Following Primary Total Hip Arthroplasty
- 16 July 2014
- journal article
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 96 (14) , 1201-1209
Abstract
He risk of readmission following total hip arthroplasty. Methods: Using the American College of Surgeons–National Surgical Quality Improvement Program data for 2011, a study population was identified using the Current Procedural Terminology code for primary total hip arthroplasty (27130). The sample was stratified into readmitted and non-readmitted cohorts. Demographic variables, preoperative comorbidities, laboratory values, operative characteristics, and surgical outcomes were compared between the groups using univariate and multivariate logistic regression models. Results: Of the 9441 patients, there were 345 readmissions (3.65%) within the first thirty days following surgery. Comorbidities that increased the risk for readmission were diabetes (p < 0.001), chronic obstructive pulmonary disease (p < 0.001), bleeding disorders (p < 0.001), preoperative blood transfusion (p = 0.035), corticosteroid use (p < 0.001), dyspnea (p = 0.001), previous cardiac surgery (p = 0.002), and hypertension (p < 0.001). A multivariate regression model was used to control for potential confounders. Having a body mass index of ≥40 kg/m2 (odds ratio, 1.941 [95% confidence interval, 1.019 to 3.696]; p = 0.044) and using corticosteroids preoperatively (odds ratio, 2.928 [95% confidence interval, 1.731 to 4.953]; p < 0.001) were independently associated with a higher likelihood of readmission, and a high preoperative serum albumin (odds ratio, 0.688 [95% confidence interval, 0.477 to 0.992]; p = 0.045) was independently associated with a lower risk for readmission. Postoperative surgical site infection, pulmonary embolism, deep venous thrombosis, and sepsis (p < 0.001) were also independent risk factors for readmission. Conclusions: The risk of readmission following total hip arthroplasty increases with growing preoperative comorbidity burden, and is specifically increased in patients with a body mass index of ≥40 kg/m2, a history of corticosteroid use, and low preoperative serum albumin and in patients with postoperative surgical site infection, a thromboembolic event, and sepsis. Level of Evidence: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence....Keywords
This publication has 30 references indexed in Scilit:
- Postoperative Complication Rates in the “Super-Obese” Hip and Knee Arthroplasty PopulationThe Journal of Arthroplasty, 2012
- Age and Obesity Are Risk Factors for Adverse Events After Total Hip ArthroplastyClinical Orthopaedics and Related Research, 2012
- Decreased Length of Stay After TKA Is Not Associated With Increased Readmission Rates in a National Medicare SampleClinical Orthopaedics and Related Research, 2012
- Complications after hip arthroplasty and the association with hospital procedure volumeActa Orthopaedica, 2011
- Risk Factors for 30-Day Postoperative Complications and Mortality after Below-Knee Amputation: A Study of 2,911 Patients from the National Surgical Quality Improvement ProgramJournal of the American College of Surgeons, 2011
- Short-Term Outcomes after Laparoscopic-Assisted Proctectomy for Rectal Cancer: Results from the ACS NSQIPJournal of the American College of Surgeons, 2011
- 2010 Mid-America Orthopaedic Association Physician in Training Award: Predictors of Early Adverse Outcomes after Knee and Hip Arthroplasty in Geriatric PatientsClinical Orthopaedics and Related Research, 2011
- Design and statistical methodology of the National Surgical Quality Improvement Program: why is it what it is?The American Journal of Surgery, 2009
- Trends in mortality, complications, and demographics for primary hip arthroplasty in the United StatesInternational Orthopaedics, 2008
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987